People on the Move: Outsourcing-Pharma roundup July ‘19
CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.
Archives for August 2, 2019
IBS treatment market growing at CAGR of 10% to 2026
The IBS treatment market will develop to be worth $3.3bn by 2026, driven by increased uptake of small molecule treatments and growing incidence.